Bruno Julianne sold CRSP
March 11, 2025 · Form 4 insider transaction
Bruno Julianne sold 1,198 shares of CRISPR Therapeutics AG at $42.42 per share, a transaction worth $50.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,198
Price
$42.42
Total value
$50.8K
InsiderBruno Julianne
RoleOfficer, Director
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateMarch 11, 2025
Filing dateMarch 12, 2025
Shares owned after8,263
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.